Potential 2-2 reversal on the daily back into FTFC??NYSE:MRK
Potential 2-2 reversal on the daily could flip the weekly, monthly and quarter back green.
Long
Merck & Co., Inc.
No trades
No trades
Compare with Merck & Co., Inc.
Key facts today
3.08 EUR
15.54 B EUR
55.28 B EUR
2.47 B
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Details
Sector
Industry
CEO
Robert M. Davis
Website
Headquarters
Rahway
Founded
1891
IPO date
Jan 1, 1941
ISIN
US58933Y1055
CUSIP
58933Y105
FIGI
BBG00GQ6S6Z0
Identifiers
ISIN US58933Y1055
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Long
MRK Long — Failed breakdown on the 4h pullback flips bullish jusThe aligned 4h pullback with a clean failed-breakdown trigger and modest extension sets up a 2.3R long; the positive trial readout, multiple analyst upgrades, and FDA nod supply fresh fundamental fuel that aligns with the bullish price-action read.
📍 Entry: 123.86
🛑 Stop: 121.19
🎯 Target: 130.00
⚖️
Long
Merck: Has Resistance Become Support?Merck has been sneaking higher, and some traders may think the drugmaker has broken out.
The first pattern on today’s chart is the February 25 peak of $125.14. MRK pushed above that level two weeks ago, before pulling back to bounce at the previous high. Has old resistance become new support?
Seco
May 2, 2026 MRK. Continued stock growth.- Exchange: Bitget TradFi
- Instrument: MRKon
- Timeframe: Weekly
- Trade type: Buy stop order
- Price: 114.54
- Take Profit: Open
- Stop Loss: 107.90 (-5.80 %)
Idea: Long on a breakout above last week's high — bullish momentum continuation.
Entry: Buy stop above last week’s high.
Stop-loss: Below
Long
This stock may fail to make a new high
There is a high probability that this stock may fail to make a new high.
What’s your opinion?
Merck Wave Analysis – 25 May 2026
- Merck broke resistance level 115.00
- Likely to rise to resistance level 125.00
Merck opened today with the wide upward gap which broke above the resistance level 115.00, which is the upper border of the tight narrow price range inside which the price moved from the end for April.
The breakout
Long
Trade Plan: MRKTrade Plan: MRK
• Direction: Short
• Entry: 112.20
• Stop Loss: 130.00
• TP1: 95.50
• TP2: 80.00
• TP3: 66.00
Take partial profits at each target, then trail stop to protect profits.
Not financial advice.
Short
Merck & Company, Inc. (MRK) Drives Global Drug InnovationMerck & Company, Inc. (MRK) is a global pharmaceutical leader developing medicines and vaccines for cancer, infectious diseases, and chronic conditions. The company grows through blockbuster drugs, a strong research pipeline, and expanding demand for advanced therapies. Its focus on innovation and g
Long
waitTeam,
We are not buying now.
Price is still trading below major descending resistance (R).
As long as we are below R, the structure remains under pressure.
✅ What We Are Waiting For
We only buy if:
Price breaks above the descending resistance (R)
A candle closes clearly above it
We see streng
Long
Merck (MRK) Presses 52-Week Highs — Buyers Still in Control:Current Price: 122.26 (Analysis was generated on Monday Morning)
Direction: LONG
Confidence level: 64%(Price is holding near highs with strong technical structure and supportive healthcare news, but short-term social volume is limited, keeping confidence moderate.)
Targets
Target 1: 124.50
Target
Long
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
6.075% YTM
Maturity dateDec 4, 2065
Coupon5.70% (Fixed)
6.025% YTM
Maturity dateMay 17, 2063
Coupon5.15% (Fixed)
5.993% YTM
Maturity dateSep 15, 2055
Coupon5.70% (Fixed)
5.988% YTM
Maturity dateMay 22, 2056
Coupon5.85% (Fixed)
5.988% YTM
Maturity dateDec 10, 2061
Coupon2.90% (Fixed)
5.974% YTM
Maturity dateDec 4, 2055
Coupon5.55% (Fixed)
5.969% YTM
Maturity dateMar 7, 2049
Coupon4.00% (Fixed)
5.968% YTM
Maturity dateMay 17, 2053
Coupon5.00% (Fixed)
5.930% YTM
Maturity dateDec 10, 2051
Coupon2.75% (Fixed)
5.929% YTM
Maturity dateMay 22, 2046
Coupon5.75% (Fixed)
5.915% YTM
Maturity dateMar 15, 2046
Coupon5.50% (Fixed)
See all MRK bonds
Weight0.44%
Market value10.08 B
Weight0.49%
Market value8.24 B
Weight4.47%
Market value4.50 B
Weight0.51%
Market value4.39 B
Weight0.50%
Market value3.95 B
Weight1.18%
Market value3.02 B
Weight5.53%
Market value2.30 B
Weight1.38%
Market value1.79 B
Weight1.31%
Market value1.27 B
Weight4.67%
Market value955.04 M
Weight1.94%
Market value818.16 M
Explore more ETFs
Frequently asked questions
The current price of MRK is 115.20 EUR — it has increased by 0.33% in the past 24 hours. Watch Merck & Co., Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange Merck & Co., Inc. stocks are traded under the ticker MRK.
MRK stock has risen by 3.00% compared to the previous week, the month change is a 10.20% rise, over the last year Merck & Co., Inc. has showed a 61.34% increase.
We've gathered analysts' opinions on Merck & Co., Inc. future price: according to them, MRK price has a max estimate of 135.88 EUR and a min estimate of 87.66 EUR. Watch MRK chart and read a more detailed Merck & Co., Inc. stock forecast: see what analysts think of Merck & Co., Inc. and suggest that you do with its stocks.
MRK stock is 0.61% volatile and has beta coefficient of 0.28. Track Merck & Co., Inc. stock price on the chart and check out the list of the most volatile stocks — is Merck & Co., Inc. there?
Today Merck & Co., Inc. has the market capitalization of 284.57 B, it has increased by 2.26% over the last week.
Yes, you can track Merck & Co., Inc. financials in yearly and quarterly reports right on TradingView.
Merck & Co., Inc. is going to release the next earnings report on Aug 4, 2026. Keep track of upcoming events with our Earnings Calendar.
MRK earnings for the last quarter are −1.11 EUR per share, whereas the estimation was −1.28 EUR resulting in a 13.15% surprise. The estimated earnings for the next quarter are −0.24 EUR per share. See more details about Merck & Co., Inc. earnings.
Merck & Co., Inc. revenue for the last quarter amounts to 14.10 B EUR, despite the estimated figure of 13.72 B EUR. In the next quarter, revenue is expected to reach 14.32 B EUR.
MRK net income for the last quarter is −3.67 B EUR, while the quarter before that showed 2.52 B EUR of net income which accounts for 0.00% change. Track more Merck & Co., Inc. financial stats to get the full picture.
Yes, MRK dividends are paid quarterly. The last dividend per share was 0.73 EUR. As of today, Dividend Yield (TTM)% is 2.56%. Tracking Merck & Co., Inc. dividends might help you take more informed decisions.
Merck & Co., Inc. dividend yield was 3.12% in 2025, and payout ratio reached 45.05%. The year before the numbers were 3.14% and 46.32% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 25, 2026, the company has 75 K employees. See our rating of the largest employees — is Merck & Co., Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Merck & Co., Inc. EBITDA is 20.87 B EUR, and current EBITDA margin is 45.17%. See more stats in Merck & Co., Inc. financial statements.
Like other stocks, MRK shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Merck & Co., Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Merck & Co., Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Merck & Co., Inc. stock shows the strong buy signal. See more of Merck & Co., Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.